|
Quarter Ended |
|
Year-To-Date Ended |
||||
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
(thousands of US dollars, except per share amounts) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
272,800 |
|
283,496 |
|
557,602 |
|
560,279 |
Net income |
29,939 |
|
39,019 |
|
64,384 |
|
74,794 |
|
|
|
|
|
|
|
|
Income tax expense |
10,474 |
|
14,981 |
|
23,323 |
|
28,628 |
Net finance income |
(2,680) |
|
(5,932) |
|
(5,440) |
|
(12,106) |
Depreciation and amortization |
13,354 |
|
13,047 |
|
26,924 |
|
25,700 |
EBITDA (1) |
51,087 |
|
61,115 |
|
109,191 |
|
117,016 |
|
|
|
|
|
|
|
|
Net income attributable to equity holders of the Company |
30,205 |
|
38,825 |
|
64,781 |
|
74,347 |
Net (loss) income attributable to non-controlling interests |
(266) |
|
194 |
|
(397) |
|
447 |
Net income |
29,939 |
|
39,019 |
|
64,384 |
|
74,794 |
|
|
|
|
|
|
|
|
Basic and diluted earnings per share (cents) |
49 |
|
61 |
|
105 |
|
116 |
1 EBITDA is not a recognized measure under IFRS Accounting Standards (IFRS). Management believes that in addition to net income, this measure provides useful supplemental information to investors including an indication of cash available for distribution prior to debt service, capital expenditures, payment of lease liabilities and income taxes. Investors should be cautioned, however, that this measure should not be construed as an alternative to net income, determined in accordance with IFRS, as an indicator of the Company's performance. The Company's method of calculating this measure may differ from other companies and, accordingly, the results may not be comparable. |
(presented in US dollars)
Forward-looking statements: Certain statements made in the following Management's Discussion and Analysis contain forward-looking statements including, but not limited to, statements concerning possible or assumed future results of operations of the Company. Forward-looking statements represent the Company's intentions, plans, expectations and beliefs, and are not guarantees of future performance. Such forward-looking statements represent
Financial Performance
Net income attributable to equity holders of the Company (Earnings) for the second quarter of 2025 of
For the six months ended
Operating Segments and Product Groups
The Company provides three distinct types of packaging technologies: a) flexible packaging, b) rigid packaging and flexible lidding and c) packaging machinery. Each is deemed to be a separate operating segment.
The flexible packaging segment includes the modified atmosphere packaging, specialty films and biaxially oriented nylon product groups. Modified atmosphere packaging extends the shelf life of perishable foods, while at the same time maintains or improves the quality of the product. The packaging is used for a wide range of markets and applications, including fresh and processed meats, poultry, cheese, medical device packaging, high performance pouch applications and high-barrier films for converting applications. Specialty films include a full line of barrier and non-barrier films which are ideal for converting applications such as printing, laminating and bag making, including shrink bags. Biaxially oriented nylon film is stretched by length and width to add stability for further conversion using printing, metalizing or laminating processes and is ideal for food packaging applications such as cheese, fluid and viscous liquids, and industrial applications such as book covers and balloons.
The rigid packaging and flexible lidding segment includes the rigid containers, lidding and specialized printed packaging product groups. Rigid containers include portion control and single-serve containers, as well as plastic sheet, custom and retort trays, which are used for applications such as food, pet food, beverage, dairy, industrial and healthcare. Lidding products are available in die-cut, daisy chain and rollstock formats and are used for applications such as food, dairy, beverage, pet food, industrial and healthcare. Specialized printed packaging provides packaging solutions to the pharmaceutical, healthcare, nutraceutical, cosmetic and personal care markets.
Packaging machinery includes a full line of horizontal fill/seal machines for preformed containers and vertical form/fill/seal pouch machines for pumpable liquid and semi-liquid products and certain dry products.
Revenue
Revenue in the second quarter of 2025 was
For the first six months of 2025, revenue fell by 0.5 percent to
Gross Profit Margins
Gross profit margins in the current quarter of 29.4 percent of revenue declined by 3.1 percentage points from the 2024 second quarter result of 32.5 percent of revenue. Raw material cost reductions were accompanied by a similar magnitude of selling price decreases, which included concessions stemming from heightened competitive pressures in the modified atmosphere packaging market. The Company's cost structure was adversely affected by higher personnel and quality related expenses. Personnel expenses included an aggregate of
Gross profit margins in the first six months of 2025 contracted by 1.5 percentage points to 30.3 percent of revenue from the 31.8 percent recorded in the 2024 year-to-date comparative period. Higher selling prices, resulting from the change in product mix, combined with a decline in raw material costs, raised Earnings by
During the second quarter of 2025, the raw material purchase price index was unchanged compared to the first quarter of 2025. Polypropylene resin increased by 5 percent while nylon resin experienced a decrease of 7 percent. Over the past 12 months, the index dropped by 6 percent.
Expenses and Other
Operating expenses in the second quarter of 2025, exclusive of foreign exchange, progressed at a rate of 3.7 percent whereas sales volumes decreased by 3.1 percent, resulting in a reduction in Earnings of
On a year-to-date basis, operating expenses, adjusted for foreign exchange, advanced at a rate of 2.8 percent in comparison to the 0.3 percent reduction in sales volumes, thereby having an unfavorable impact on Earnings of
Capital Resources, Cash Flow and Liquidity
On
The Company's cash and cash equivalents balance ended the second quarter of 2025 at
For the first half of 2025, the cash and cash equivalents balance declined by
Summary of Quarterly Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thousands of US dollars, except per share amounts (US cents) |
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q2 |
|
Q1 |
|
Q4 |
|
Q3 |
|
Q2 |
|
Q1 |
|
Q4 |
|
Q3 |
|
2025 |
|
2025 |
|
2024 |
|
2024 |
|
2024 |
|
2024 |
|
2023 |
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
272,800 |
|
284,802 |
|
285,143 |
|
285,473 |
|
283,496 |
|
276,783 |
|
275,637 |
|
273,790 |
Net income attributable to equity holders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of the Company |
30,205 |
|
34,576 |
|
36,622 |
|
38,486 |
|
38,825 |
|
35,522 |
|
34,846 |
|
33,991 |
EPS |
49 |
|
56 |
|
58 |
|
61 |
|
61 |
|
55 |
|
54 |
|
52 |
Looking Forward
Despite the challenges and uncertainties relating to the current trade environment,
With the exception of foil-based products, the Company's entire product portfolio is presently exempt from tariffs under
For the balance of 2025, onboarding new business opportunities will be the key to achieving sales volume growth. Recently added extrusion capacity within the modified atmosphere packaging facility will continue to be a key contributor, targeting the dairy market. In addition, the initiation of recently awarded pet food and healthcare business will expand volumes. Based on the preceding factors, sales volume growth for the remainder of 2025 should reflect a modest improvement over relatively flat volume growth posted for the first half of 2025.
Raw material costs have moved within a narrow range over the past six months. Market expectations are that overall resin and foil prices will be relatively stable for the balance of the year. The Company is optimistic that the majority of the foil import tariffs will be passed along to customers. Going forward, the additional manufacturing costs relating to waste and quality should be curtailed significantly.
Capital expenditures of approximately
Interim Condensed Consolidated Financial Statements
Second Quarter Ended:
These interim condensed consolidated financial statements have not been audited or reviewed by the Company's independent external auditors,
|
|
|
|
|
|
Condensed Consolidated Balance Sheets |
|
|
|
|
|
(thousands of US dollars) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
|
|
356,030 |
|
497,261 |
Trade and other receivables |
|
|
213,356 |
|
220,201 |
Income taxes receivable |
|
|
15,224 |
|
8,749 |
Inventories |
|
|
270,718 |
|
250,383 |
Prepaid expenses |
|
|
9,589 |
|
6,710 |
Derivative financial instruments |
|
|
905 |
|
- |
|
|
|
865,822 |
|
983,304 |
|
|
|
|
|
|
Non-current assets: |
|
|
|
|
|
Property, plant and equipment |
|
|
641,873 |
|
622,666 |
Intangible assets and goodwill |
|
|
29,434 |
|
29,709 |
Employee benefit plan assets |
|
|
11,443 |
|
11,405 |
|
|
|
682,750 |
|
663,780 |
Total assets |
|
|
1,548,572 |
|
1,647,084 |
|
|
|
|
|
|
Equity and Liabilities |
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
Trade payables and other liabilities |
|
|
117,587 |
|
252,134 |
Contract liabilities |
|
|
1,566 |
|
1,747 |
Income taxes payable |
|
|
1,432 |
|
6,879 |
Derivative financial instruments |
|
|
233 |
|
4,175 |
|
|
|
120,818 |
|
264,935 |
|
|
|
|
|
|
Non-current liabilities: |
|
|
|
|
|
Employee benefit plan liabilities |
|
|
4,241 |
|
4,774 |
Deferred income |
|
|
19,565 |
|
19,721 |
Provisions and other long-term liabilities |
|
|
15,756 |
|
16,781 |
Deferred tax liabilities |
|
|
61,094 |
|
56,999 |
|
|
|
100,656 |
|
98,275 |
Total liabilities |
|
|
221,474 |
|
363,210 |
|
|
|
|
|
|
Equity: |
|
|
|
|
|
Share capital |
|
|
27,415 |
|
27,735 |
Reserves |
|
|
492 |
|
(3,174) |
Retained earnings |
|
|
1,264,372 |
|
1,224,097 |
Total equity attributable to equity holders of the Company |
|
|
1,292,279 |
|
1,248,658 |
Non-controlling interests |
|
|
34,819 |
|
35,216 |
Total equity |
|
|
1,327,098 |
|
1,283,874 |
Total equity and liabilities |
|
|
1,548,572 |
|
1,647,084 |
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Income |
|
|
|
|
|
|
|
|
|
(thousands of US dollars, except per share amounts) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended |
|
Year-To-Date Ended |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
272,800 |
|
283,496 |
|
557,602 |
|
560,279 |
Cost of sales |
|
|
(192,594) |
|
(191,431) |
|
(388,851) |
|
(382,022) |
Gross profit |
|
|
80,206 |
|
92,065 |
|
168,751 |
|
178,257 |
|
|
|
|
|
|
|
|
|
|
Sales, marketing and distribution expenses |
|
|
(23,992) |
|
(24,418) |
|
(48,315) |
|
(49,067) |
General and administrative expenses |
|
|
(13,646) |
|
(12,414) |
|
(26,235) |
|
(25,134) |
Research and technical expenses |
|
|
(5,764) |
|
(5,435) |
|
(11,342) |
|
(10,731) |
Pre-production expenses |
|
|
(127) |
|
- |
|
(280) |
|
- |
Other income (expenses) |
|
|
1,056 |
|
(1,730) |
|
(312) |
|
(2,009) |
Income from operations |
|
|
37,733 |
|
48,068 |
|
82,267 |
|
91,316 |
Finance income |
|
|
3,754 |
|
7,094 |
|
7,889 |
|
14,628 |
Finance expense |
|
|
(1,074) |
|
(1,162) |
|
(2,449) |
|
(2,522) |
Income before income taxes |
|
|
40,413 |
|
54,000 |
|
87,707 |
|
103,422 |
Income tax expense |
|
|
(10,474) |
|
(14,981) |
|
(23,323) |
|
(28,628) |
Net income for the period |
|
|
29,939 |
|
39,019 |
|
64,384 |
|
74,794 |
|
|
|
|
|
|
|
|
|
|
Attributable to: |
|
|
|
|
|
|
|
|
|
Equity holders of the Company |
|
|
30,205 |
|
38,825 |
|
64,781 |
|
74,347 |
Non-controlling interests |
|
|
(266) |
|
194 |
|
(397) |
|
447 |
|
|
|
29,939 |
|
39,019 |
|
64,384 |
|
74,794 |
|
|
|
|
|
|
|
|
|
|
Basic and diluted earnings per share - cents |
|
|
49 |
|
61 |
|
105 |
|
116 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Comprehensive Income |
|
|
|
|
|
|
|
|
|
(thousands of US dollars) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended |
|
Year-To-Date Ended |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
|
Net income for the period |
|
|
29,939 |
|
39,019 |
|
64,384 |
|
74,794 |
|
|
|
|
|
|
|
|
|
|
Items that will not be reclassified to the statements of income: |
|
|
|
|
|
|
|
|
|
Cash flow hedge (losses) gains recognized |
|
|
- |
|
(354) |
|
57 |
|
(1,160) |
Cash flow hedge losses transferred to property, plant and equipment |
|
|
- |
|
115 |
|
378 |
|
64 |
|
|
|
- |
|
(239) |
|
435 |
|
(1,096) |
Items that are or may be reclassified subsequently to the statements of income: |
|
|
|
|
|
|
|
|
|
Cash flow hedge gains (losses) recognized |
|
|
2,540 |
|
(508) |
|
2,832 |
|
(1,563) |
Cash flow hedge losses transferred to the statements of income |
|
|
734 |
|
344 |
|
1,580 |
|
352 |
Income tax effect |
|
|
(876) |
|
44 |
|
(1,181) |
|
324 |
|
|
|
2,398 |
|
(120) |
|
3,231 |
|
(887) |
Other comprehensive income (loss) for the period - net of income tax |
|
|
2,398 |
|
(359) |
|
3,666 |
|
(1,983) |
Comprehensive income for the period |
|
|
32,337 |
|
38,660 |
|
68,050 |
|
72,811 |
|
|
|
|
|
|
|
|
|
|
Attributable to: |
|
|
|
|
|
|
|
|
|
Equity holders of the Company |
|
|
32,603 |
|
38,466 |
|
68,447 |
|
72,364 |
Non-controlling interests |
|
|
(266) |
|
194 |
|
(397) |
|
447 |
|
|
|
32,337 |
|
38,660 |
|
68,050 |
|
72,811 |
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Changes in Equity |
|
|
|
|
|
|
|
(thousands of US dollars) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Attributable to equity holders of the Company |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non- |
|
|
|
Share |
|
Retained |
|
controlling |
|
|
|
capital |
Reserves |
earnings |
Total |
interests |
Total equity |
|
|
|
|
|
|
|
|
Balance at |
|
29,195 |
1,361 |
1,319,491 |
1,350,047 |
33,602 |
1,383,649 |
|
|
|
|
|
|
|
|
Comprehensive (loss) income for the period |
|
|
|
|
|
|
|
Cash flow hedge losses, net of tax |
|
- |
(2,305) |
- |
(2,305) |
- |
(2,305) |
Cash flow hedge losses transferred to the statements |
|
|
|
|
|
|
|
of income, net of tax |
|
- |
258 |
- |
258 |
- |
258 |
Cash flow hedge losses transferred to property, plant and |
|
|
|
|
|
|
|
equipment |
|
- |
64 |
- |
64 |
- |
64 |
Other comprehensive loss |
|
- |
(1,983) |
- |
(1,983) |
- |
(1,983) |
Net income for the period |
|
- |
- |
74,347 |
74,347 |
447 |
74,794 |
Comprehensive (loss) income for the period |
|
- |
(1,983) |
74,347 |
72,364 |
447 |
72,811 |
|
|
|
|
|
|
|
|
Dividends |
|
- |
- |
(2,818) |
(2,818) |
- |
(2,818) |
Repurchase of common shares |
|
(876) |
- |
(63,250) |
(64,126) |
- |
(64,126) |
|
|
|
|
|
|
|
|
Balance at |
|
28,319 |
(622) |
1,327,770 |
1,355,467 |
34,049 |
1,389,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
27,735 |
(3,174) |
1,224,097 |
1,248,658 |
35,216 |
1,283,874 |
|
|
|
|
|
|
|
|
Comprehensive income (loss) for the period |
|
|
|
|
|
|
|
Cash flow hedge gains, net of tax |
|
- |
2,131 |
- |
2,131 |
- |
2,131 |
Cash flow hedge losses transferred to the statements |
|
|
|
|
|
|
|
of income, net of tax |
|
- |
1,157 |
- |
1,157 |
- |
1,157 |
Cash flow hedge losses transferred to property, plant and |
|
|
|
|
|
|
|
equipment |
|
- |
378 |
- |
378 |
- |
378 |
Other comprehensive income |
|
- |
3,666 |
- |
3,666 |
- |
3,666 |
Net income (loss) for the period |
|
- |
- |
64,781 |
64,781 |
(397) |
64,384 |
Comprehensive income (loss) for the period |
|
- |
3,666 |
64,781 |
68,447 |
(397) |
68,050 |
|
|
|
|
|
|
|
|
Dividends |
|
- |
- |
(4,400) |
(4,400) |
- |
(4,400) |
Repurchase of common shares |
|
(320) |
- |
(20,106) |
(20,426) |
- |
(20,426) |
|
|
|
|
|
|
|
|
Balance at |
|
27,415 |
492 |
1,264,372 |
1,292,279 |
34,819 |
1,327,098 |
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows |
|
|
|
|
|
|
|
(thousands of US dollars) (unaudited) |
|
|
|
|
|
|
|
|
Quarter Ended |
|
Year-To-Date Ended |
||||
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
Cash provided by (used in): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities: |
|
|
|
|
|
|
|
Net income for the period |
29,939 |
|
39,019 |
|
64,384 |
|
74,794 |
Items not involving cash: |
|
|
|
|
|
|
|
Depreciation |
13,507 |
|
13,086 |
|
27,193 |
|
25,766 |
Amortization - deferred income |
(499) |
|
(426) |
|
(965) |
|
(844) |
Amortization - intangible assets |
346 |
|
387 |
|
696 |
|
778 |
Employee defined benefit plan expenses |
676 |
|
697 |
|
1,357 |
|
1,356 |
Net finance income |
(2,680) |
|
(5,932) |
|
(5,440) |
|
(12,106) |
Income tax expense |
10,474 |
|
14,981 |
|
23,323 |
|
28,628 |
Other |
(949) |
|
(652) |
|
(1,311) |
|
(1,017) |
Cash flow from operating activities before the following |
50,814 |
|
61,160 |
|
109,237 |
|
117,355 |
Change in working capital: |
|
|
|
|
|
|
|
Trade and other receivables |
5,747 |
|
(12,509) |
|
6,801 |
|
(7,131) |
Inventories |
(10,153) |
|
(9,951) |
|
(20,335) |
|
(7,320) |
Prepaid expenses |
(346) |
|
1,754 |
|
(2,879) |
|
159 |
Trade payables and other liabilities |
2,443 |
|
(1,180) |
|
(5,140) |
|
10,995 |
Contract liabilities |
370 |
|
391 |
|
(181) |
|
(528) |
|
|
|
|
|
|
|
|
Employee defined benefit plan contributions |
(1,220) |
|
(19) |
|
(1,238) |
|
(1,174) |
Income tax paid |
(15,921) |
|
(23,803) |
|
(30,900) |
|
(34,598) |
Interest received |
3,637 |
|
6,686 |
|
7,443 |
|
14,078 |
Interest paid |
(973) |
|
(1,062) |
|
(2,204) |
|
(2,328) |
Net cash from operating activities |
34,398 |
|
21,467 |
|
60,604 |
|
89,508 |
|
|
|
|
|
|
|
|
Investing activities: |
|
|
|
|
|
|
|
Acquisition of property, plant and equipment - net |
(26,537) |
|
(27,086) |
|
(45,934) |
|
(74,429) |
Acquisition of intangible assets |
(151) |
|
(9) |
|
(419) |
|
(32) |
|
(26,688) |
|
(27,095) |
|
(46,353) |
|
(74,461) |
|
|
|
|
|
|
|
|
Financing activities: |
|
|
|
|
|
|
|
Payment of lease liabilities |
(509) |
|
(402) |
|
(911) |
|
(799) |
Dividends paid |
(2,155) |
|
(1,436) |
|
(135,399) |
|
(2,907) |
Repurchase of common shares |
(5,474) |
|
(56,567) |
|
(19,172) |
|
(62,878) |
|
(8,138) |
|
(58,405) |
|
(155,482) |
|
(66,584) |
|
|
|
|
|
|
|
|
Change in cash and cash equivalents |
(428) |
|
(64,033) |
|
(141,231) |
|
(51,537) |
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period |
356,458 |
|
554,366 |
|
497,261 |
|
541,870 |
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of period |
356,030 |
|
490,333 |
|
356,030 |
|
490,333 |
SOURCE